Vectura Group (VEC)

 

VEC Share PerformanceMore

52 week high200.10 12/01/16
52 week low135.00 25/08/16
52 week change -28.20 (-16.97%)
4 week volume30,267,829 30/07/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Vectura triggers $8m milestone for Exparel

Vectura Group said a sales milestone receipt of $8m has been triggered following confirmation by Pacira Pharmaceuticals...

US$8 million Exparel? sales milestone from Pacira

RNS Number: 3617G Vectura Group plc 05 August 2016 Vectura Group plc US$8 million Exparel sales milestone from Pacira triggered This announcement includes inside information Chippenham, UK - 5 August 2016: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading inhaled airways disease focused business, announces that a sales milesto...

Director/PDMR Shareholding

RNS Number: 9783F Vectura Group plc 02 August 2016 Vectura Group plc Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (in accordance with the Market Abuse Regulations) Chippenham, UK, 2 August 2016: Vectura Group plc (LSE: VEC; "Vectura" or "the Company") co...

Total Voting Rights and Capital

RNS Number: 8224F Vectura Group plc 01 August 2016 Vectura Group plc (the "Company") VOTING RIGHTS AND CAPITAL Chippenham, UK, 1 August 2016: In accordance with the Financial Conduct Authority's Transparency Directive, Transitional Provision6, Vectura Group plc (LSE: VEC) ("the Company") wishes to notify the market of the following: The Co...

Broker Forecast - Numis issues a broker note on Vectura Group PLC

Numis today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and set its price target at 246p.

Vectura initiates legal proceedings against GSK

RNS Number: 4443F Vectura Group plc 27 July 2016 Vectura Group plc Vectura initiates legal proceedings against GSK relating to option-to-licence patent agreement and confirms 2016 revenue guidance This announcement includes inside information Chippenham, UK - 27 July 2016: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading inha...

Change of accounting reference date

RNS Number: 9274E Vectura Group plc 22 July 2016 Vectura Group plc Change of accounting reference date Chippenham, UK - 22 July 2016: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading inhaled airways disease focused business, announces that the Board has approved a change in its accounting reference date from 31 March to 31 D...

Holding(s) in Company

RNS Number: 0727E Vectura Group plc 13 July 2016 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii VECTURA GROUP PLC 2 Reason for the notification (please ti...

Fundamental DataMore

P/E ratio115
EPS1.2
Dividend yield0 %

Latest discussion posts More

  • Re: USA and costs of Bio products hits S...

    ShareCast News) - UK equities were dragged lower by pharmaceutical shares on Thursday following remarks from US presidential candidate Hillary Clinton on cutting prices of ...
    25-Aug-2016
    d gaser
  • Re: USA and costs of Bio products hits S...

    Andy Im not at all happy at the moment with my pharma/Bio portfolio as it is red right across the board at the moment .But as you know Andy, we have both been here before and ...
    25-Aug-2016
    d gaser
  • Re: USA and costs of Bio products hits S...

    Has this spooked the drug market? http://www.foxnews.com/health/2016/08/24/epipen-was-mylan-ceos-baby-now-shes-in-hot-seat.html Mylan has now agreed to reduce the price ...
    25-Aug-2016
    raptor66

Users' HoldingsMore

Users who hold Vectura Group also hold..
LLOYDS GRP.28%
VODAFONE GRP.23%
BP20%
TESCO17%
BARCLAYS16%

Codes & Symbols

ISINGB00B01D1K48
SymbolsVEC, LSE:VEC, VEC.L, VEC:LN, LON:VEC, XLON:VEC